Insulin-like growth factor I receptor signaling in differentiation of neuronal H19-7 cells

Cancer Research

Volumn 60, Issue 8, 2000, Pages 2263-2272

  Morrione, Andrea ^a   Romano, Gaetano ^a   Navarro, Magali ^a   Reiss, Krzysztof ^a   Valentinis, Barbara ^a   Dews, Michael ^a   Eves, Eva ^b   Rosner, Marsha Rich ^b   Baserga, Renato ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN C;

ANIMAL CELL; ARTICLE; ENZYME ACTIVATION; MITOGENESIS; NERVE CELL DIFFERENTIATION; NEUROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADAPTOR PROTEINS, VESICULAR TRANSPORT; AMINO ACID SUBSTITUTION; ANIMALS; CELL DIFFERENTIATION; CELL DIVISION; CELL LINE; ENZYME ACTIVATION; FIBROBLASTS; HIPPOCAMPUS; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MAP KINASE SIGNALING SYSTEM; MICE; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; MUTATION; NEURONS; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEINS; RATS; RECEPTOR, IGF TYPE 1; TEMPERATURE;

EID: 0034655171     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (78)

1. Baserga, R. Oncogenes and the strategy of growth factors. Cell, 79: 927-930, 1994.
2. Baserga, R., Prisco, M., and Hongo, A. IGFs and cell growth. In: R. G. Rosenfeld and C. T. Roberts, Jr. (eds.), The IGF System, pp. 329-353. Totowa, NJ: Humana Press, 1999.
3. Petley, T., Graff, K., Jiang, W., and Florini, J. Variation among cell types in the signaling pathways by which IGF-I stimulates specific cellular responses. Horm. Metab. Res., 31: 70-76, 1999.
4. Liu, Q., Ning, W., Dantzer, R., Freund, G. G., and Kelley, K. K. Activation of protein kinase C-ζ and phosphatidylinositol 3′-kinase and promotion of macrophage differentiation by insulin-like growth factor I. J. Immunol., 160: 1393-1401, 1998.
5. McMorris, F. A., Smith, T. M., Desalvo, S., and Furlanetto, R. W. Insulin-like growth factor I/Somatomedin-C: a potent inducer of oligodendrocyte development. Proc. Natl. Acad. Sci. USA, 83: 822-826, 1986.
6. Mill, J. F., Chao, M. V., and Ishii, D. N. Insulin, insulin-like growth factor II, and nerve growth factor effects on tubulin mRNA levels and neurite formation. Proc. Natl. Acad. Sci. USA, 82: 7126-7130, 1985.
7. Recio-Pinto, E., Lanf, F. F., and Ishii, D. N. Insulin and insulin-like growth factor II permit nerve growth factor binding and the neurite formation response in cultured human neuroblasloma cells. Proc. Natl. Acad. Sci. USA, 81: 2562-2566, 1984.
8. Kim, B., Leventhal, P. S., Saltiel, A. R., and Feldman, E. L. Insulin-like growth factor-I-mediated neurite outgrowth in vitro requires mitogen-activated protein kinase activation. J. Biol. Chem., 272: 21268-21273, 1997.
9. Leventhal, P. S., Russell, J. W., and Feldman, E. L. IGFs and the nervous system. In: R. G. Rosenfeld and C. T. Roberts, Jr. (eds.), The IGF System, pp. 425-455. Totowa, NJ: Humana Press, 1999.
10. Anlar, B., Sullivan, K. A., and Feldman, E. L. Insulin-like growth factor I and central nervous system development. Horm. Metab. Res., 31: 126-132, 1999.
11. Arsenijevic, Y., and Weiss, S. Insulin-like growth factor-I is a differentiation factor for postmitotic CNS stem cell-derived neuronal precursors: distinct actions from those of brain-derived neurotrophic factor. J. Neurosci., 18: 2118-2128, 1998.
12. Eves, E. M., Tucker, M. S., Roback, J. D., Downen, M., Rosner, M. R., and Wainer, B. H. Immortal rat hippocampal cell lines exhibit neuronal and glial lineages and neurotrophin gene expression. Proc. Natl. Acad. Sci. USA, 89: 4373-4377, 1992.
13. Eves, E. M., Kwon, J., Downen, M., Tucker, M. S., Wainer, B. H., and Rosner, M. R. Conditional immortalization of neuronal cells from postmitotic cultures and adult CNS. Brain Res., 656: 396-404, 1994.
14. Eves, E. M., Boise, L. H., Thompson, C. B., Wagner, A. J., Hay, N., and Rosner, M. R. Apoptosis induced by differentiation or serum deprivation in an immortalized central nervous system neuronal cell line. J. Neurochem., 67: 1908-1920, 1996.
15. Renfranz, P. J., Cunningham, M. G., and McKay, R. D. G. Region-specific differentiation of the hippocampal stem cell line HiB5 upon implantation into the developing mammalian brain. Cell, 66: 713-729, 1991.
16. Whittemore, S. R., and White, L. A. Target regulation of neuronal differentiation in a temperature-sensitive cell line derived from medullary raphe. Brain Res., 615: 27-40, 1993.
17. Kim, B., Cheng, H-L., Margolis, B., and Feldman, E. L. Insulin receptor substrate 2 and Shc play different roles in insulin-like growth factor I signaling. J. Biol. Chem., 273: 34543-34550, 1998.
18. Kim, B., Leventhal, P. S., White, M. F., and Feldman, E. L. Differential regulation of insulin receptor substrate-2 and mitogen-activated protein kinase tyrosine phosphorylation by phosphatidylinositol 3-kinase inhibitors in SH-SY5Y human neuroblastoma cells. Endocrinology, 139: 4881-4889, 1998.
19. Rubini, M., Hongo, A., D'Ambrosio, C., and Baserga, R. The IGF-I receptor in mitogenesis and transformation of mouse embryo cells: role of receptor number. Exp. Cell Res., 230: 284-292, 1997.
20. Pietrzkowski, Z., Lammers, R., Carpenter, G., Soderquist, A. M., Limardo, M., Phillips, P. D., Ullrich, A., and Baserga, R. Constitutive expression of insulin-like growth factor I and insulin-like growth factor I receptor abrogates all requirements for exogenous growth factors. Cell Growth Differ., 3: 199-205, 1992.
21. Romano, G., Prisco, M., Zanocco Marani, T., Peruzzi, F. Valentinis, B., and Baserga, R. Dissociation between resistance to apoptosis and the transformed phenotype in IGF-1 receptor signaling. J. Cell. Biochem., 72: 294-310, 1999.
22. Ullrich, A., Gray, A., Tam, A. W., Yang-Feng, T., Tsubokawa, M., Collins, C., Henzel, W., Le Bon, T., Kahuria, S., Chen, E., Jakobs, S., Francke, U., Ramachandran, J., and Fujita-Yamaguchi, Y. Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J., 5: 503-512, 1986.
23. DeAngelis, T., Ferber, A., and Baserga, R. Insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the platelet-derived growth factor receptor. J. Cell. Physiol., 164: 214-221, 1995.
24. Li, S., Resnicoff, M., and Baserga, R. Effect of mutations at serines 1280-1283 on the mitogenic and transforming activities of the insulin-like growth factor I receptor. J. Biol. Chem. 271: 12254-12260, 1996.
25. Miura, M., Li, S., and Baserga, R. Effect of a mutation at tyrosine 950 of the insulin-like growth factor 1 receptor on the growth and transformation of cells. Cancer Res., 55: 663-667, 1995.
26. Kuo, W. L., Abe, M., Rhee, J., Eves, E. M., McCarthy, S. A., Yan, M., Templeton, D. J., McMahon, M., and Rosner, M. R. Raf, but not MEK or ERK, is sufficient for differentiation of hippocampal neuronal cells. Mol. Cell. Biol., 16: 1458-1470, 1996.
27. Kuo, W. L., Chung, K. C., and Rosner, M. R. Differentiation of central nervous system neuronal cells by fibroblast-derived growth factor requires at least two signaling pathways: roles for Ras and Src. Mol. Cell. Biol., 17: 4633-4643, 1997.
28. Reiss, K., Valentinis, B., Tu, X., Xu, S. Q., and Baserga, R. Molecular markers of IGF-I-mediated mitogenesis. Exp. Cell Res., 242: 361-372, 1998.
29. Morrione, A., Valentinis, B., Li, S., Ooi, J. Y. T., Margolis, B., and Baserga, R. Grb10: a new substrate of the insulin-like growth factor 1 receptor. Cancer Res., 56: 3165-3167, 1996.
30. Morrione, A., Valentinis, B., Xu, S. Q., Yumet, G., Louvi, A., Efstratiadis, A., and Baserga, R. Insulin-like growth factor II stimulates cell proliferation through the insulin receptor. Proc. Natl. Acad. Sci. USA, 94: 3777-3782, 1997.
31. Morrione, A., Valentinis, B., Resnicoff, M., Xu, S., and Baserga, R. The role of mGrb10α in insulin-like growth factor 1-mediated growth. J. Biol. Chem., 272: 26382-26387, 1997.
32. Prisco, M., Romano, G., Peruzzi, F., Valentinis, B., and Baserga, R. Insulin and IGF-1 receptors signaling in protection from apoptosis. Horm. Metab. Res., 31: 81-89, 1999.
33. Miura, M., Surmacz, E., Burgaud, J-L., and Baserga, R. Different effects on mitogenesis and transformation of a mutation at tyrosine 1251 of the insulin-like growth factor I receptor. J. Biol. Chem., 270: 22639-22644, 1995.
34. Li, S., Ferber, A., Miura, M., and Baserga, R. Mitogenicity and transforming activity of the insulin-like growth factor-1 receptor with mutations in the tyrosine kinase domain. J. Biol. Chem., 269: 32558-32564, 1994.
35. Hongo, A., D'Ambrosio, C., Miura, M., Morrione, A., and Baserga, R. Mutational analysis of the mitogenic and transforming activities of the insulin-like growth factor I receptor. Oncogene, 12: 1231-1238, 1996.
36. O'Connor, R., Kauffmann-Zeh, A., Liu, Y., Lehar, S., Evan, G. L. Baserga, R., and Bläuler, W. A. The IGF-1 receptor domains for protection from apoptosis are distinct from those required for proliferation and transformation. Mol. Cell. Biol., 17: 427-435, 1997.
37. Surmacz, E., Sell, C., Swantek, J., Kato, H., Roberts, C. T., Jr., LeRoith, D., and Baserga, R. Dissociation of mitogenesis and transforming activity by C-terminal truncation of the insulin-like growth factor I receptor. Exp. Cell Res., 218: 370-380, 1995.
38. Valentinis, B., Porcu, P., Quinn, K., and Baserga, R. The role of the insulin-like growth factor I receptor in the transformation by simian virus 40 T antigen. Oncogene, 9: 825-831, 1994.
39. 2 progression in the estradiol-induced mitotic cycle. Proc Natl. Acad. Sci. USA, 96: 3287-3291, 1999.
40. Yenush, L., Makati, K. J., Smith-Hall, J., Ishibashi, O., Myers, M. G., Jr., and White, M. F. The pleckstrin homology domain is the principal link between the insulin-receptor and IRS-1. J. Biol. Chem., 271: 24300-24306, 1996.
41. Pronk, G. J., McGlade, J., Pelicci, G., Pawson, T., and Bos, J. L. Insulin-induced phosphorylation of the 46- and 52-kDa Shc proteins. J. Biol. Chem., 268: 5748-5753, 1993.
42. Craparo, A., O'Neill, T. J., and Gustafson, T. A. Non-SH2 domains within insulin receptor substrate-1 and SHC mediate their phosphotyrosine-dependent interaction with the NPEY motif of the insulin-like growth factor-I receptor. J. Biol. Chem., 270: 15639-15643, 1995.
43. Araki, E., Lipes, M. A., Patti, M. E., Bruning, J. C., Haag, B., III. Johnson, R. S., and Kahn, C. R. Alternative pathway of insulin signaling in mice with targeted disruption of the IRS-1 gene. Nature (Lond.), 372: 186-190, 1994.
44. White, M. F. The IRS-signalling system: a network of docking proteins that mediate insulin action. Mol. Cell. Biochem., 182: 3-11, 1998.
45. Myers, M. G., Sun, X. J., Cheatham, B., Jachna, B. R., Glasheen, E. M., Backer, J. M., and White, M. F. IRS-1 is a common element in insulin and insulin-like growth factor-1 signaling to the phosphatidylinositol 3′-kinase. Endocrinology, 132: 1421-1430, 1993.
46. Eves, E. M., Xiong, W., Bellacosa, A., Kennedy, S. G., Tsichlis, P. N., Rosner, M. R., and Hay, N. Akt, a target of phosphatidylinositol 3-kinase, inhibits apoptosis in a differentiating neuronal cell line. Mol. Cell. Biol., 18: 2143-2152, 1998.
47. Kennedy, S. G., Wagner, A. J., Conzen, S. D., Jordan, J., Bellacosa, A., Tsichlis, P. N., and Hay, N. The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev., 11: 701-713, 1997.
48. Kulik, G., Klippel, A., and Weber, M. J. Antiapoptotic signaling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt. Mol. Cell. Biol., 17: 1595-1606, 1497.
49. Dudek, H., Datta, S. R., Franke, T. F. Birnbaum, M. J., Yao, R., Cooper, G. M., Segal, R. A., Kaplan, D. R., and Greenberg, M. E. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science (Washington DC), 275: 661-665, 1997.
50. Datta, S. R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., and Greenberg, M. E. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell. 91: 231-241, 1997.
51. Myers, M. G., Jr., Wang, I.-M., Sun, X. J., Zhang, Y., Yenush, L., Schlessinger, J., Pierce, J. H., and White, M. F. Role of IRS-1-GRB-2 complexes in insulin signalling. Mol. Cell. Biol., 14: 3577-3587, 1994.
52. Hugl, S. R., White, M. F., and Rhodes, C. J. Insulin-like growth faclor I (IGF-1)-stimulated pancreatic β-cell growth is glucose-dependent. J. Biol. Chem., 273: 17771-17779, 1998.
53. Ogawa, W., Matozaki, T., and Kasuga, M. Role of binding proteins to IRS-1 in insulin signaling. Mol. Cell. Biochem., 182: 13-22, 1998.
54. Favata, M. F., Horiuchi, K. Y., Manos, E. J., Daulerio, A. J., Stradley, D. A., Feeser, W. S., Van Dyk, D. E., Pitts, W. J., Earl, R. A., Hobbs, F., Copeland, R. A., Magolda, R. L., Scherle, P A., and Traskos, J. M. Indentification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem., 273: 18623-18632, 1998.
55. LeRoith, D., Roberts, C. T., Jr., Werner, H., Bondy, C., Raizada, M., and Adamo, M. I. Insulin-like growth factors in the brain. In: S. E. Loughlin and J. H. Fallon (eds.), Neurotrophic Factors, pp 391-414. Academic Press, 1992.
56. LeRoith, D., Werner, H., Faria, T. N., Kato, H., Adamo, M., and Roberts, C. T., Jr. Insulin-like growth factor receptors: implications for central nervous system function. Ann. N. Y. Acad. Sci., 692: 22-32, 1993.
57. Baserga, R., Hongo, A., Rubini, M., Prisco, M., and Valentinis, B. The IGF-1 receptor in cell growth, transformation and apoptosis. Biochim. Biophys. Acta. 1332: 105-126, 1997.
58. Valentinis, B., Romano, G., Peruzzi, E., Morrione, A., Prisco, A., Soddu, S., Cristofanelli, B., Sacchi, A., and Baserga, R. Growth and differentiation signals by the insulin-like growth factor receptor in hemopoietic cells are mediated through different pathways. J. Biol. Chem., 274: 12423-12430, 1999.
59. Lin, H-Y., Xu, J., Ischenko, I., Ornitz, D. M., Halegoua, S., and Hayman, M. J. Identification of the cytoplasmic regions of fibroblast growth factor (FGE) receptor I which play important roles in induction of neurite outgrowth in PC12 cells by FGF-1. Mol. Cell. Biol., 18: 3762-3770, 1998.
60. Dews, M., Nishimoto, I., and Baserga, R. IGF-I receptor protection from apoptosis in cells lacking the IRS proteins. Recept. Signal Transduct., 7: 231-239, 1998.
61. Ceresa, B. P., Jao, A. W., Santeler, S. R., and Pessin, J. E. Inhibition of clathrin-mediated endocytosis selectively attenuates specific insulin receptor signal transduction pathways. Mol. Cell. Biol., 18: 3862-3870, 1998.
62. Craparo, A., Freunds, R., and Gustafson, T. A. 14-3-3 (∈) interacts with the insulin-like growth factor I receptor and insulin receptor substrate 1 in a phosphoserine-dependent manner. J. Biol. Chem., 272: 11663-11669, 1997
63. Furlanetto, R. W., Dey, B. R., Opaczynski, W., and Nissley, S. P. 14-3-3 proteins interact with the insulin-like growth factor receptor but not the insulin receptor. Biochem. J., 327: 765-771, 1997.
64. Dent, P., Jelinek, T., Morrison, D. K., Weber, M. J., and Sturgill, T. W. Reversal of Raf-1 activation by purified and membrane-associated protein phosphatases. Science (Washington DC), 268: 1902-1906, 1995.
65. Li, S., Janosch, P., Tanji, M., Rosenfeld, G. C., Waymire, J. C., Mischak, H., Kolch, W., and Sedivy, J. M. Regulation of Raf-1 kinase activity by the 14-3-3 family proteins. EMBO J., 14: 685-696, 1995.
66. Tzivion, G., Luo, Z., and Avruch, J. A dimeric 14-3-3 protein is an essential cofactor for Raf kinase activity. Nature (Lond.), 394: 88-92, 1998.
67. Roy, S., McPherson, R. A., Apolloni, A., Yan, J., Lane, A., Clyde-Smith, J., and Hancock, J. F. 14-3-3 facilitates Ras-dependent Raf-1 activation in vitro and in vivo. Mol. Cell. Biol., 18: 3947-3955, 1998.
68. Thorson, J. A., Yu, L. W. K., Hsu, A. L., Shih, N-Y., Graves, P. R., Tanner, J. W., Allen, P. M., Piwnica-Worms, H., and Shaw, A. S. 14-3-3 proteins are required for maintenance of Raf-1 phosphorylation and kinase activity. Mol. Cell. Biol., 18: 5229-5238, 1998.
69. Peruzzi, F., Prisco, M., Dews, M., Salomoni, P., Grassilli, E., Romano, G., Calabretta, B., and Baserga, R. Multiple signaling pathways of the IGF-1 receptor in protection from apoptosis. Mol. Cell. Biol., 19: 7203-7215, 1999.
70. Baserga, R., and Morrione, A. Differentiation, and malignant transformation: two roads diverged in a wood. J. Cell. Biochem. Suppl., 32: 68-75, 1999.
71. mpkk) in fibroblasts. J. Cell Biol., 122: 1079-1088, 1993.
72. Marshall, C. J. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell. 80: 179-185, 1995.
73. Khokhlatchev, A. V., Canagarajah, B., Wilsbacher, J., Robinson, M., Atkinson, M., Goldsmith, E., and Cobb, M. H. Phosphorylation of the MAP kinase ERK2 promotes its homodimerization and nuclear translocation. Cell, 93: 605-615, 1998.
74. Hadari, Y. R., Kouhara, H., Lax, I., and Schlessinger, J. Binding of Shp2 tyrosine phosphatase to FRS2 is essential for fibroblast growth factor-induced PC12 cell differentiation. Mol. Cell. Biol., 18: 3966-3973, 1998.
75. York, R. D., Yao, H., Dillon, T., Ellig, C. L,. Eckert, S. P., McDleskey, E. W., and Stork, P. J. S. Rap1 mediates sustained MAP kinase activation induced by nerve growth factor. Nature (Lond.), 392: 622-626, 1998.
76. Nguyen, T. T., Scimeca, J. C., Fillouix, C., Peraldi, P., Carpentier, J. L., and van Obberghen, E. Co-regulation of the mitogen-activated protein kinase, extra-cellular signal-regulated kinase 1, and the 90-kDa ribosomal S6 kinase in PC12 cells. J. Biol. Chem., 268: 9803-9810, 1993.
77. Zhou-Li, F., D'Ambrosio, D., Lis, S., Surmacz, E., and Baserga, R. Association of insulin receptor substrate 1 with simian virus 40 large T antigen. Mol. Cell. Biol., 15: 4232-4239, 1995.
78. Zhou-Li, F., Xu, S-Q., Dews, M., and Baserga, M. Co-operation of simian virus 40 T antigen and insulin receptor substrate-1 in protection from apoptosis induced by interleukin-3 withdrawal. Oncogene, 15: 961-970, 1997.